Nat Aging 6 , 5667 (2026)
Eghdami S, Eissazade N, Heidari Mokarar M, Boroon M, Orsolini L, Shalbafan M
Amersi thinks patients can benefit from microdosing now, even without data to prove its efficacy, if they work with a doctor to carefully monitor their response
If you are considering Semaglutide in Jupiter, the next step is not to guess whether it is right for you
Lysons message is simple: Listen to your body, follow screening guidelines and know that GLP-1s arent always the golden ticket theyre made out to be
Gut microbiota-derived imidazole propionate: an emerging target for the prevention and treatment of cardiometabolic diseases